Evidence map›Paper›PMID 35403786›Full record

ArticleJournal of cosmetic dermatology2023

Efficacy and tolerability of a microneedling device for treating wrinkles on the face.

Mona Alqam, Christine E Wamsley, Thomas M Hitchcock, Brian C Jones, Yucel Akgul, Jeffrey M Kenkel

Registry-linked trialOpen access · hybridAbstract read
In one paragraph

Article in Journal of cosmetic dermatology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03803059 (A Single-Center Trial to Evaluate the Efficacy and Tolerability of SkinPen on Male and Female Subjects' Wrinkles of the Neck), which is not on this map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03803059 nacompletednot on this map

A Single-Center Trial to Evaluate the Efficacy and Tolerability of SkinPen on Male and Female Subjects' Wrinkles of the Neck

TypeinterventionalSponsorBellus Medical, LLCRan2019 to 2020Enrolled35ConditionsWrinklesArmsSkinPen Precision
3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Mona AlqamMedical Affairs & Clinical Development, Crown Laboratories, Dallas, Texas, USA.
Christine E WamsleyDepartment of Plastic Surgery, UT Southwestern Medical Center, Dallas, Texas, USA.
Thomas M HitchcockScientific Affairs, Crown Laboratories, Dallas, Texas, USA.
Brian C JonesMedical Affairs & Clinical Development, Crown Laboratories, Dallas, Texas, USA.
Yucel AkgulDepartment of Plastic Surgery, UT Southwestern Medical Center, Dallas, Texas, USA.
Jeffrey M KenkelClinical Center for Cosmetic Laser Treatment and Department of Plastic Surgery, UT Southwestern Medical Center, Dallas, Texas, USA.
CRO Laboratories (United States) · USSouthwestern Medical CenterThe University of Texas Southwestern Medical Center · US

Funding

Bellus MedicalCrown Aesthetics
6 · The paper itself

Abstract

objectivesA microneedling pen has been cleared by the US Food and Drug Administration, indicated for improving the appearance of adult facial acne scars. The objective of this study was to assess the device's effectiveness for treating wrinkles of the face area. MATERIALS AND

methodsHealthy adults seeking to improve the appearance of face wrinkles were enrolled (N = 35), receiving four monthly microneedling procedures by a trained aesthetician who treated the face skin per manufacturer instructions. Wrinkle assessments were performed by two trained blinded raters by comparing baseline images of each subject with images obtained at 90 days post-procedure. Subsequently, the two raters were unblinded for the Clinician's Global Aesthetic Improvement Scale (CGAIS) assessment. Subjects completed the Subject's Global Aesthetic Improvement Scale (SGAIS) and a Satisfaction Questionnaire at 30 and 90 days post-treatment.

resultsThe study was completed by 32 subjects with a mean (SD) age of 56.3 (5.0) years. Wrinkle assessments demonstrated significant improvement in the face areas (p < 0.001). The SGAIS scores showed significant improvements after 30 and 90 days post-treatment (for each, p < 0.001). The CGAIS scores also showed significant improvements at 90 days post-treatment (p < 0.001). Most subjects reported some level of improvement in their appearance at 30 days (73.3%) and 90 days (68.8%) post-treatment. The satisfaction questionnaire showed high levels of improvement in wrinkles (93.8%), satisfaction with the treatment procedure (87.5%) and would recommend microneedling to friends and family members (80.6%) on the face and neck.

conclusionMicroneedling is a viable, minimally invasive option for treating wrinkles of the face. CLINICALTRIALS: gov Identifier: NCT03803059.

Indexed as

Cosmetic TechniquesSkin AgingAcne VulgarisAdultCicatrixHumansMiddle AgedSkinTreatment Outcomeclinical trialefficacymicroneedlingwrinkles

Identifiers

PMID35403786
PMCPMC10084046
OpenAlexW4223471069

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.